Categories AlphaGraphs, Earnings, Health Care
Infographic: Key highlights from Merck’s (MRK) Q2 2023 earnings results
Merck (NYSE: MRK) reported second quarter 2023 earnings results today.
Total worldwide sales were $15 billion, up 3% from the same period a year ago.
GAAP net loss was $5.9 billion, or $2.35 per share, compared to net income of $3.9 billion, or $1.55 per share, last year. Adjusted loss per share was $2.06.
For the full year of 2023, the company expects sales of $58.6-59.6 billion and adjusted EPS of $2.95-3.05.
Prior performance
Most Popular
Trxade Health Inc. (NASDAQ: MEDS) Q1 2024 Research Summary
Trxade Health, Inc. (NASDAQ: MEDS) is a drug procurement and delivery platform that digitalizes the retail pharmacy experience. The company has a growing network of suppliers and partnerships with independent
Earnings Preview: Walmart (WMT) expected to report sales and profit gains in Q1
Over the years, Walmart Inc. (NYSE: WMT) has constantly diversified while maintaining its dominance in the retail world. The company is preparing to report financial results for the first three
What to look for when Take-Two Interactive Software (TTWO) reports Q4 2024 earnings results
Shares of Take-Two Interactive Software, Inc. (NASDAQ: TTWO) stayed red on Thursday. The stock has dropped 14% over the past three months. The gaming company is scheduled to report its